Clinical trial

Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS…

NCT00002472 · Mayo Clinic, Other · Completed

Key facts

NCT number NCT00002472
Title Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors
Official title Phase II Pre-Irradiation Chemotherapy for Central Nervous System Germ Cell Malignancies
Lead sponsor Mayo Clinic, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Brain and Central Nervous System Tumors, Pediatric Germ Cell Tumor, Extragonadal Germ Cell Tumor
Intervention type Drug, Procedure, Radiation
Interventions cisplatin, etoposide, conventional surgery, neoadjuvant therapy, radiation therapy
Start date Mar 1, 1991
Primary completion Aug 1, 2005
Completion Aug 1, 2005
First posted Jan 27, 2003
Last update posted Mar 15, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies